Skin Cancer Screening and Education at Beaches

Skin Cancer Clinical Trial

— SHADE  

Official title:

Skin Cancer Screening and Education Program at Beaches

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00894855
• Other study ID #: 14598
• Status: Completed
• Phase: N/A
• First received: May 6, 2009
• Last updated: December 30, 2014
• Start date: January 2007
• Est. completion date: November 2008

Study information

• Verified date: December 2014
• Source: Dana-Farber Cancer Institute
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Interventional

Clinical Trial Summary

This study was an evaluation of the Dana-Farber Cancer Institute Blum Family Resource Center Van's existing skin cancer screening and education program. This program occurred over 2 summers. This study will fill a critical gap in the investigators' knowledge about how best to address the high-risk behaviors that regularly occur during the summertime at beaches. The investigators randomized beaches to receive different combinations of the van program components in order to determine how services should optimally be configured to maximize impact. The investigators hypothesized that providing all three components (1-Skin cancer prevention education; 2-Biometric feedback using a Dermascan Analyzer that illustrates skin damage due to sun exposure and Ultra Violet (UV) Reflectance Photography; and 3-Dermatologist skin exam) will maximize knowledge and behavior change, relative to education alone.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 634
• Est. completion date: November 2008
• Est. primary completion date: November 2008
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Beachgoers eligible to participate in the study included:

• those who were 18 years and older

• Caucasian

• able to understand, speak and read English

• ability to give informed consent

• had not already enrolled in the study at another participating beach

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Prevention

Related Conditions & MeSH terms

• Skin Cancer
• Skin Neoplasms

Intervention

Behavioral:
• education about sun protection
This comprehensive education program included a visit with a health educator, on the education van, who gave education about sun safety.
• biometric feedback
Participants received biometric feedback using a Dermascan Analyzer and Ultra Violet (UV) Reflectance Photography. The Dermascan Analyzer is an educational tool that enhances visibility of skin texture, markings or lesions and is commonly used in health fairs and at schools all over the country. The analyzer highlights the sun damage on the participants skin as dark purple blotches, which the participants are able to see in the mirror placed inside the analyzer. Ultra Violet (UV) Reflectance Photography provides participants with a visual image of their skin damage that can be taken with them.

Other:
• dermatologist skin exam
Full body skin exam.

Locations

Country	Name	City	State
United States	Dana-Farber Cancer Institute	Boston	Massachusetts

Sponsors (5)

Lead Sponsor	Collaborator
Dana-Farber Cancer Institute	Brigham and Women's Hospital, Harvard Medical School, The Shilling SHADE Foundation of America, University of Massachusetts, Amherst

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	sun protection behaviors		4-6 months post-intervention	No
Primary	sun burns		4-6 months post-intervention	No
Primary	skin self-exams		4-6 months post-intervention	No